Anti-CD40 predominates over anti-CTLA-4 to provide enhanced antitumor response of DC-CIK cells in renal cell carcinoma.
Frontiers in immunology
View this publicationFrontiers in immunology
View this publicationBiology
View this publicationJAMA ophthalmology
View this publicationMolecular nutrition & food research
View this publicationFrontiers in nephrology
View this publicationAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
View this publicationEuropean journal of cancer (Oxford, England : 1990)
View this publicationJournal of perinatal medicine
View this publicationAlzheimer's & dementia : the journal of the Alzheimer's Association
View this publicationAlzheimer's & dementia : the journal of the Alzheimer's Association
View this publication